Published by Coherent Market Insights
Posted on September 14, 2021
3 min readLast updated: February 10, 2026
Add as preferred source on Google
Sexual health is an important part of a person’s physical and mental health. According to the World Health Organization (WHO), sexual health requires a respectful and positive approach to sexual relationships and sexuality, as well as the possibility of having pleasurable and safe sexual experiences, free of coercion, violence, and discrimination. Sexual health leads to a healthy sex life without any sexually transmitted diseases, and to take preventive measures to avoid sexually transmitted infections. The elderly population (geriatric population) often suffer from one or more sexual disorders, such as premature (early) ejaculation, erectile dysfunctions, dyspareunia, and hypoactive sexual desire disorder, among others.
Thus, with the increasing geriatric population worldwide, the prevalence/incidence of sexual disorders is also increasing, driving the growth of the sexual health market. According to WHO, the world’s population aged 60 years and older is expected to total 2 billion by 2050, up from 900 million in 2015? Moreover, the sexual health market is gaining huge traction due to the emergence of COVID-19 (pandemic), an infectious disease caused by the newly discovered coronavirus. According to the analysis from Save the Children, disruption due to COVID-19 could lead to 23,000 extra teenage pregnancies by the end of 2020.
To combat this, in June 2020, Sierra Leone launched an innovative, interactive game app for boys and girls which provides reliable information on sexual health as well as how to stay safe from the coronavirus. Furthermore, growth of the sexual health market, in the Asia Pacific, is mainly driven by the increasing prevalence of sexual disorders, increasing geriatric population, and increasing awareness among people about the sexual health. For example, in June 2018, the Indian Medical Association (IMA) launched a nationwide sexual health program aimed to eradicate the social taboo related to sexual medical conditions.
IMA also planned to release e-bulletins on male and female sexual dysfunction and encourage sessions once in three months for doctors in its branches across India. The idea was to focus on medical problems related with sexual health. However, side effects associated with drugs used to treat sexual dysfunctions, such as hearing loss, visual changes, facial flushing, and long-lasting erection, may hamper demand, as well as the sexual health market growth. Moreover, increasing cases of untreated or undiagnosed sexual health problems may restrain growth of the market. Regional segmentation of the sexual health market includes North America, South America, Asia Pacific, Europe, the Middle East, and Africa.
Top Key Players Include In Sexual Health Market Market: Teva Pharmaceutical Industries Ltd., Meda Pharmaceuticals, Inc., Eli Lilly & Company, Bayer AG, Vivus, Inc., Zydus Pharmaceuticals, IVFTECH APS, Merck & Co., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Novartis International AG, Mylan Pharmaceuticals Inc., and AstraZeneca.
Get This premium report with Instant US$ 2000 discount @ https://www.coherentmarketinsights.com/promo/buynow/3364
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
The post Sexual Health Market Is Expected to Generate Global Revenue Worth US$ 10,697.3 million by 2027 appeared first on Gatorledger.
The sexual health market is projected to generate global revenue worth US$ 10,697.3 million by 2027.
The increasing geriatric population worldwide is driving the growth of the sexual health market due to a higher prevalence of sexual disorders.
In June 2020, Sierra Leone launched an interactive game app aimed at providing reliable information on sexual health and safety.
Key players in the sexual health market include Teva Pharmaceutical Industries Ltd., Meda Pharmaceuticals, Eli Lilly & Company, Bayer AG, and Vivus, Inc.
IMA plans to release e-bulletins on sexual dysfunction and conduct quarterly sessions for doctors to focus on medical professionals' education.
Explore more articles in the Research Reports category
